Hsin Yang Liu

Corporate Officer/Principal presso TSH BIOPHARM CORPORATION LIMITED

Health Technology

Consumer Services

Profilo

Hsin Yang Liu is currently the Vice General Manager-General Administration at TSH Biopharm Corp., Ltd.
Previously, she held the position of VP-Administrative, Director-Accounting & Finance at Body Organ Biomedical Corp.
in 2012.
She also served as a Member-Supervisory Board at Reber Genetics Co., Ltd.
Dr. Liu completed her undergraduate and graduate degrees at National Taiwan University and obtained a doctorate degree from Nankai University.

Posizioni attive di Hsin Yang Liu

Società	Posizione	Inizio
TSH BIOPHARM CORPORATION LIMITED	Corporate Officer/Principal	-

Tutte le posizioni attive di Hsin Yang Liu

Precedenti posizioni note di Hsin Yang Liu

Società	Posizione	Fine
REBER GENETICS CO LTD	Direttore/Membro del Consiglio	-
BODY ORGAN BIOMEDICAL CORP	Direttore Finanziario/CFO	-

Vedi nel dettaglio l'esperienza di Hsin Yang Liu

Formazione di Hsin Yang Liu

National Taiwan University	Graduate Degree
Nankai University	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Hsin Yang Liu

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
TSH BIOPHARM CORPORATION LIMITED	Health Technology

Aziende private	2
Body Organ Biomedical Corp. Body Organ Biomedical Corp. BiotechnologyHealth Technology Body Organ Biomedical Corp. engages in the research, development, manufacture and sales of biomedical devices. It also provides regenerative solutions to restore tissue damage in orthopedics, dentistry, ophthalmology, reconstructive and general surgery. The company was founded on May 4, 2007 and is headquartered in Taipei, Taiwan.	Health Technology
Reber Genetics Co., Ltd. Reber Genetics Co., Ltd. Pharmaceuticals: MajorHealth Technology Reber Genetics Co., Ltd. engages in the research, development, production, and sale of animal vaccines. Its products include PRRS and PCV2 subunit vaccines. The company was founded on April 18, 2008 and is headquartered in Taipei, Taiwan.	Health Technology

Aziende private